Wilson Sonsini advised RxSight, and Davis Polk advised the sole bookrunning manager in the offering.RxSight, Inc. announced a $50 million SEC-registered follow-on offering of 4,000,000 shares…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Pietro Martinoia
…
This content is for Standard 1 Year members only. LoginJoin Now